Tox21_300265

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

72 Suppliers, 21 USDMF, 16 CEP/COS, 13 JDMF, 7 EU WC, 20 KDMF, 27 NDC API, 42 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

469 Dossiers, 99 FDA Orange Book, 121 Europe, 34 Canada, 60 South Africa, 155 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 2%, TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG, TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG, SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1%, SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 48 BASF, 38 Kerry, 24 Roquette, 18 Corel Pharma Chem, 16 Microlex e.U, 15 Seppic, 15 Actylis, 14 Ideal Cures Pvt Ltd, 12 Sigachi Industries, 12 Gangwal Chemicals, 11 Nanjing Well Pharmaceutical, 11 SPI Pharma, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 7 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 DKSH, 4 Alcedo Pharmachem, 4 Ingredion Pharma Solutions, 4 Ulanqab Kema New Material, 3 Kima Chemical, 3 Doshion Polyscience, 3 Aeon Procare, 3 Finar, 2 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Evonik, 2 Shandong Focus Biotechnology Co., Ltd, 2 Lubrizol Life Science Health, 2 Nanjing Bold Chemical, 2 Seqens, 2 Nomisma Healthcare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Shanghai Welltone Material Technology Co., Ltd, 1 BioSpectra, 1 Qualicaps, 1 Rochem International Inc, 1 Pfanstiehl, 1 Huzhou Sunflower Pharmaceutical, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 72 Coating Systems & Additives, 50 Controlled & Modified Release, 46 Solubilizers, 45 Direct Compression, 42 Disintegrants & Superdisintegrants, 36 Thickeners and Stabilizers, 34 Granulation, 34 Topical, 25 Parenteral, 24 Lubricants & Glidants, 22 Film Formers & Plasticizers, 20 Taste Masking, 18 Co-Processed Excipients, 15 Emulsifying Agents, 10 Chewable & Orodispersible Aids, 9 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

27 US Medicaid Prescriptions, 117 Finished Drug Prices

MARKET PLACE

58 APIs, 23 DOSSIERS // FDF

PATENTS

26 US Patents, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 63 News

Information, Expiry & Status of Health Canada Patents covering Tox21_300265.

Tox21_300265

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

72 Suppliers

21 USDMF

16 CEP/COS

13 JDMF

7 EU WC

20 KDMF

27 NDC API

42 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

469 Dossiers

99 FDA Orange Book

121 Europe

34 Canada

60 South Africa

155 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 2%

TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG

TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG

SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1%

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

48 BASF

38 Kerry

24 Roquette

18 Corel Pharma Chem

16 Microlex e.U

15 Seppic

15 Actylis

14 Ideal Cures Pvt Ltd

12 Sigachi Industries

12 Gangwal Chemicals

11 Nanjing Well Pharmaceutical

11 SPI Pharma

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

7 DFE Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 Prachin Chemical

4 DKSH

4 Alcedo Pharmachem

4 Ingredion Pharma Solutions

4 Ulanqab Kema New Material

3 Kima Chemical

3 Doshion Polyscience

3 Aeon Procare

3 Finar

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Evonik

2 Shandong Focus Biotechnology Co., Ltd

2 Lubrizol Life Science Health

2 Nanjing Bold Chemical

2 Seqens

2 Nomisma Healthcare

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Shanghai Welltone Material Technology Co., Ltd

1 BioSpectra

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 1.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;TOPICAL - 3% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons